Anaphylaxis epidemiology and demographics: Difference between revisions

	Anaphylaxis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Anaphylaxis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Anaphylaxis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Anaphylaxis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Anaphylaxis epidemiology and demographics
CDC on Anaphylaxis epidemiology and demographics
Anaphylaxis epidemiology and demographics in the news
Blogs on Anaphylaxis epidemiology and demographics
Directions to Hospitals Treating Anaphylaxis
Risk calculators and risk factors for Anaphylaxis epidemiology and demographics

VisualWikitext

Latest revision as of 09:43, 15 April 2021

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Dushka Riaz, MD

Epidemiology and Demographics

Prevalence

In 2006, the lifetime prevalence of Anaphylaxis was estimated to be 0.05% to 2% in the United States. However it is believed that this is an underestimation because the disease is underdiagnosed. ^[1]

Case-fatality rate/Mortality rate

The mortality rate of Anaphylaxis is approximately 186 to 225 deaths/year. ^[2]

Age

Patients of all age groups may develop anaphylaxis, however, children and adolescents account for the majority of cases.^[3]

Race

There is no racial predilection to anaphylaxis.

Gender

Anaphylaxis affects men and women equally with more women being admitted to the hospital for the disease. ^[1]

Region

There is no regional predilection to anaphylaxis.

Developed Countries

An estimated 1.24% to 16.8% of the United States population is considered at risk for developing anaphylaxis if they are exposed to one or more allergens. Anaphylaxis results in fewer than 1,000 deaths per year in the U.S and the most common presentation is cardiovascular collapse ^[4] ^[5]

References

↑ ^1.0 ^1.1 LoVerde D, Iweala OI, Eginli A, Krishnaswamy G (2018). "Anaphylaxis". Chest. 153 (2): 528–543. doi:10.1016/j.chest.2017.07.033. PMC 6026262. PMID 28800865.
↑ Ma L, Danoff TM, Borish L (2014). "Case fatality and population mortality associated with anaphylaxis in the United States". J Allergy Clin Immunol. 133 (4): 1075–83. doi:10.1016/j.jaci.2013.10.029. PMC 3972293. PMID 24332862.
↑ Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A; et al. (2006). "Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group". Ann Allergy Asthma Immunol. 97 (5): 596–602. doi:10.1016/S1081-1206(10)61086-1. PMID 17165265.
↑ Neugut, Alfred, Anita Ghatak and Rachel Miller. "Anaphylaxis in the United States: An Investigation Into Its Epidemiology." Arch Intern Med. 161.108 January 2001 15-21. 29 January 2007 <http://archinte.ama-assn.org/cgi/content/full/161/1/15>.
↑ "FASTSTATS - Deaths and Mortality". Retrieved 2013-02-13.

Template:WikiDoc Sources CME Category::Cardiology

[pmid28800865-1] 1.0 ^1.1 LoVerde D, Iweala OI, Eginli A, Krishnaswamy G (2018). "Anaphylaxis". Chest. 153 (2): 528–543. doi:10.1016/j.chest.2017.07.033. PMC 6026262. PMID 28800865.

[pmid24332862-2] Ma L, Danoff TM, Borish L (2014). "Case fatality and population mortality associated with anaphylaxis in the United States". J Allergy Clin Immunol. 133 (4): 1075–83. doi:10.1016/j.jaci.2013.10.029. PMC 3972293. PMID 24332862.

[pmid17165265-3] Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A; et al. (2006). "Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group". Ann Allergy Asthma Immunol. 97 (5): 596–602. doi:10.1016/S1081-1206(10)61086-1. PMID 17165265.

[4] Neugut, Alfred, Anita Ghatak and Rachel Miller. "Anaphylaxis in the United States: An Investigation Into Its Epidemiology." Arch Intern Med. 161.108 January 2001 15-21. 29 January 2007 <http://archinte.ama-assn.org/cgi/content/full/161/1/15>.

[urlFASTSTATS_-_Deaths_and_Mortality-5] "FASTSTATS - Deaths and Mortality". Retrieved 2013-02-13.

[1]

[2]

[3]

[4]

[5]

@@ Line 4: / Line 4: @@
 ==Epidemiology and Demographics==
-===Incidence===
-*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
-*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 ===Prevalence===
-*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
-*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
+*In 2006, the lifetime [[prevalence]] of [[Anaphylaxis]] was estimated to be 0.05% to 2% in the United States. However it is believed that this is an underestimation because the [[disease]] is underdiagnosed. <ref name="pmid28800865">{{cite journal| author=LoVerde D, Iweala OI, Eginli A, Krishnaswamy G| title=Anaphylaxis. | journal=Chest | year= 2018 | volume= 153 | issue= 2 | pages= 528-543 | pmid=28800865 | doi=10.1016/j.chest.2017.07.033 | pmc=6026262 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28800865  }} </ref>
-*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 ===Case-fatality rate/Mortality rate===
-*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
-*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
+*The [[mortality rate]] of [[Anaphylaxis]] is approximately 186 to 225 deaths/year. <ref name="pmid24332862">{{cite journal| author=Ma L, Danoff TM, Borish L| title=Case fatality and population mortality associated with anaphylaxis in the United States. | journal=J Allergy Clin Immunol | year= 2014 | volume= 133 | issue= 4 | pages= 1075-83 | pmid=24332862 | doi=10.1016/j.jaci.2013.10.029 | pmc=3972293 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24332862  }} </ref>
 ===Age===
-*Patients of all age groups may develop [disease name].
-*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
+*Patients of all age groups may develop [[anaphylaxis]], however, children and adolescents account for the majority of cases.<ref name="pmid17165265">{{cite journal| author=Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A | display-authors=etal| title=Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. | journal=Ann Allergy Asthma Immunol | year= 2006 | volume= 97 | issue= 5 | pages= 596-602 | pmid=17165265 | doi=10.1016/S1081-1206(10)61086-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17165265  }} </ref>
-*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
-*[Chronic disease name] is usually first diagnosed among [age group].
-*[Acute disease name] commonly affects [age group].
 ===Race===
-*There is no racial predilection to [disease name].
-*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
+*There is no racial predilection to [[anaphylaxis]].
 ===Gender===
-*[Disease name] affects men and women equally.
-*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
+*[[Anaphylaxis]] affects men and women equally with more women being admitted to the hospital for the [[disease]]. <ref name="pmid28800865">{{cite journal| author=LoVerde D, Iweala OI, Eginli A, Krishnaswamy G| title=Anaphylaxis. | journal=Chest | year= 2018 | volume= 153 | issue= 2 | pages= 528-543 | pmid=28800865 | doi=10.1016/j.chest.2017.07.033 | pmc=6026262 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28800865  }} </ref>
 ===Region===
-*The majority of [disease name] cases are reported in [geographical region].
-*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
+*There is no regional predilection to [[anaphylaxis]].
 ===Developed Countries===
-An estimated 1.24% to 16.8% of the population of the United States is considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens, especially [[penicillin]] and insect stings.  Most of these people successfully avoid their [[allergen]]s and will never experience anaphylaxis.  Of those people who actually experience anaphylaxis, up to 1% may die as a result.<ref>Neugut, Alfred, Anita Ghatak and Rachel Miller. "Anaphylaxis in the United States: An Investigation Into Its Epidemiology." Arch Intern Med. 161.108 January 2001 15-21. 29 January 2007 <http://archinte.ama-assn.org/cgi/content/full/161/1/15>.</ref>  Anaphylaxis results in fewer than 1,000 deaths per year in the U.S. (compared to 2.4 million deaths from all causes each year in the U.S.<ref name="urlFASTSTATS - Deaths and Mortality">{{cite web |url=http://www.cdc.gov/nchs/fastats/deaths.htm |title=FASTSTATS - Deaths and Mortality |format= |work= |accessdate=2013-02-13}}</ref>).  The most common presentation includes sudden cardiovascular collapse (88% of reported cases of severe anaphylaxis).
+An estimated 1.24% to 16.8% of the United States population is considered at risk for developing anaphylaxis if they are exposed to one or more [[Allergen|allergens]].
+[[Anaphylaxis]] results in fewer than 1,000 deaths per year in the U.S and the most common presentation is [[cardiovascular collapse]] <ref> Neugut, Alfred, Anita Ghatak and Rachel Miller. "Anaphylaxis in the United States: An Investigation Into Its Epidemiology." Arch Intern Med. 161.108 January 2001 15-21. 29 January 2007 <http://archinte.ama-assn.org/cgi/content/full/161/1/15>.</ref>  <ref name="urlFASTSTATS - Deaths and Mortality">{{cite web |url=http://www.cdc.gov/nchs/fastats/deaths.htm |title=FASTSTATS - Deaths and Mortality |format= |work= |accessdate=2013-02-13}}</ref>
-===Developing Countries===
 ==References==